Effective combination of corticosteroid and cyclosporine A for immunoglobulin A nephropathy with membranoproliferative glomerulonephritis features: a case report

Berger J, Hinglais N. Les ddpôts intercapillaires d’IgA-IgG [Intercapillary deposits of IgA-IgG]. J Urol Nephrol (Paris). 1968;74:694–5.

CAS  PubMed  Google Scholar 

Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829–42.

Article  CAS  PubMed  Google Scholar 

Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD Atlas of Renal Pathology: IgA nephropathy. Am J Kidney Dis. 2015;66:e33–4.

Article  PubMed  Google Scholar 

Masuda Y, Yamanaka N, Ishikawa A, Kataoka M, Arai T, Wakamatsu K, Kuwahara N, Nagahama K, Ichikawa K, Shimizu A. Glomerular basement membrane injuries in IgA nephropathy evaluated by double immunostaining for α5(IV) and α2(IV) chains of type IV collagen and low-vacuum scanning electron microscopy. Clin Exp Nephrol. 2015;19:427–35.

Article  CAS  PubMed  Google Scholar 

Nakamoto Y, Yasuda T, Imai H, Miura AB. Circumferential mesangial interposition: a form of mesangiolysis. Nephrol Dial Transplant. 1992;7:373–8.

CAS  PubMed  Google Scholar 

Hara M, Endo Y, Nihei H, Hara S, Fukushima O, Mimura N. IgA nephropathy with subendothelial deposits. Virchows Arch A Pathol Anat Histol. 1980;386:249–63.

Article  CAS  PubMed  Google Scholar 

Yoshikawa N, Ito H, Nakahara C, Yoshiara S, Yoshiya K, Matsuo T, Hasegawa O, Hazikano H, Okada S. Glomerular electron-dense deposits in childhood IgA nephropathy. Virchows Arch A Pathol Anat Histopathol. 1985;406:33–43.

Article  CAS  PubMed  Google Scholar 

Emancipator SN. IgA nephropathy: morphologic expression and pathogenesis. Am J Kidney Dis. 1994;23:451–62.

Article  CAS  PubMed  Google Scholar 

Iitaka K, Yamamoto A, Ogawa N, Sekine T, Tamai S, Motoyama O. IgA-associated glomerulonephritis with membranoproliferative glomerulonephritis-like pattern in two children. Clin Exp Nephrol. 2003;7:284–9.

Article  PubMed  Google Scholar 

Zhu J, Wang H, Yang D. IgA Nephropathy with Pathologic Features of membranoproliferative glomerulonephritis following Burn Injury. Case Rep Nephrol Urol. 2014;4:31–6.

Article  PubMed  PubMed Central  Google Scholar 

Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018;93:700–5.

Article  CAS  PubMed  Google Scholar 

Matsuzaki K, Suzuki H, Kikuchi M, Koike K, Komatsu H, Takahashi K, Narita I, Okada H, Committee of Clinical Practical Guideline for IgA Nephropathy. Current treatment status of IgA nephropathy in Japan: a questionnaire survey. Clin Exp Nephrol. 2020;2023(27):1032–41.

Google Scholar 

Wada T, Ishimoto T, Nakaya I, Kawaguchi T, Sofue T, Shimizu S, Kurita N, Sasaki S, Nishiwaki H, Koizumi M, Saito S, Nishibori N, Oe Y, Yoshida M, Miyaoka Y, Akiyama S, Itano Y, Okazaki M, Ozeki T, Ichikawa D, Oguchi H, Kohsaka S, Kosaka S, Kataoka Y, Shima H, Shirai S, Sugiyama K, Suzuki T, Son D, Tanaka T, Nango E, Niihata K, Nishijima Y, Nozu K, Hasegawa M, Miyata R, Yazawa M, Yamamoto Y, Yamamoto R, Shibagaki Y, Furuichi K, Okada H, Narita I. A digest of the Evidence-Based Clinical Practice Guideline for nephrotic syndrome 2020. Clin Exp Nephrol. 2021;25:1277–85.

Article  PubMed  Google Scholar 

Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, Ponticelli C, Saito T, Choukroun G, Nachman P, Praga M, Yoshikawa N. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int. 2007;72:1429–47.

Article  CAS  PubMed  Google Scholar 

Iijima K, Sako M, Oba MS, Ito S, Hataya H, Tanaka R, Ohwada Y, Kamei K, Ishikura K, Yata N, Nozu K, Honda M, Nakamura H, Nagata M, Ohashi Y, Nakanishi K, Yoshikawa N; Japanese Study Group of Kidney Disease in Children. Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial. Clin J Am Soc Nephrol. 2014;9:271–8.

Article  Google Scholar 

Nakopoulou L. Membranoproliferative glomerulonephritis. Nephrol Dial Transplant. 2001;16(Suppl 6):71–3.

Article  PubMed  Google Scholar 

Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993;328:465–70.

Article  CAS  PubMed  Google Scholar 

Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis–a new look at an old entity. N Engl J Med. 2012;366:1119–31.

Article  CAS  PubMed  Google Scholar 

Ferrario G, Palazzi P, Torri Tarelli L, Volpi A, Meroni M, Giordano F, Sessa A. Membranoproliferative glomerulonephritis with IgA deposits in patients with alcoholic cirrhosis. Pathologica. 1986;78:469–78.

CAS  PubMed  Google Scholar 

Andeen NK, Jefferson JA, Akilesh S, Alpers CE, Bissonnette ML, Finn LS, Higgins J, Houghton DC, Kambham N, Magil A, Najafian B, Nicosia RF, Troxell ML, Smith KD. IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury. Hum Pathol. 2018;81:272–80.

Article  PubMed  Google Scholar 

Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy. PLoS ONE. 2018;13: e0206865.

Article  PubMed  PubMed Central  Google Scholar 

Ishiko S, Horinouchi T, Fujimaru R, Shima Y, Kaito H, Tanaka R, Ishimori S, Kondo A, Nagai S, Aoto Y, Sakakibara N, Nagano C, Yamamura T, Yoshimura M, Nakanishi K, Fujimura J, Kamiyoshi N, Nagase H, Yoshikawa N, Iijima K, Nozu K. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases. Sci Rep. 2020;10:14026.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurosu A, Oka N, Hamaguchi T, Yoshikawa N, Joh K. Infantile immunoglobulin A nephropathy showing features of membranoproliferative glomerulonephritis. Tohoku J Exp Med. 2012;228:253–8.

Article  PubMed  Google Scholar 

Utsunomiya Y, Kado T, Koda T, Okada S, Hayashi A, Fukawaza A, Nakagawa T, Kanzaki S, Kasagi T. Features of IgA nephropathy in preschool children. Clin Nephrol. 2000;54:443–8.

CAS  PubMed  Google Scholar 

Yamaji K, Suzuki Y, Suzuki H, Satake K, Horikoshi S, Novak J, Tomino Y. The kinetics of glomerular deposition of nephritogenic IgA. PLoS ONE. 2014;9: e113005.

Article  PubMed  PubMed Central  Google Scholar 

Makita Y, Suzuki H, Nakano D, Yanagawa H, Kano T, Novak J, Nishiyama A, Suzuki Y. Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries. Nephrol Dial Transplant. 2022;37:1629–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoshimura M, Kida H, Abe T, Takeda S, Katagiri M, Hattori N. Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy. Am J Kidney Dis. 1987;9:404–9.

Article  CAS  PubMed  Google Scholar 

Kitamura M, Obata Y, Ota Y, Muta K, Yamashita H, Harada T, Mukae H, Nishino T. Significance of subepithelial deposits in patients diagnosed with IgA nephropathy. PLoS ONE. 2019;14: e0211812.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Katafuchi R, Ikeda K, Mizumasa T, Tanaka H, Ando T, Yanase T, Masutani K, Kubo M, Fujimi S. Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy. Am J Kidney Dis. 2003;41:972–83.

Article  CAS  PubMed  Google Scholar 

Nagasawa Y, Yamamoto R, Shinzawa M, Shoji T, Hasuike Y, Nagatoya K, Yamauchi A, Hayashi T, Kuragano T, Moriyama T, Isaka Y. Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria. Clin Exp Nephrol. 2020;24:927–34.

Article  CAS  PubMed  Google Scholar 

Coppo R, Amore A. New perspectives in treatment of glomerulonephritis. Pediatr Nephrol. 2004;19:256–65.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif